Browsing by Yonsei Author : Kim, Min Hwan

eperson profile image
Name:
Kim, Min Hwan [김민환]
orcid http://orcid.org/0000-0002-1595-6342
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)

Keyword Cloud

Researcher Network

Showing results 1 to 40 of 40

This table browses all dspace content
Issue DateTitleJournal Title
2023Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJAMA NETWORK OPEN
2023Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer CANCER RESEARCH AND TREATMENT
2023Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancerJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
2023Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer SCIENTIFIC REPORTS
2023Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA NATURE COMMUNICATIONS
2023Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14)LANCET GASTROENTEROLOGY & HEPATOLOGY
2023On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates BREAST CANCER RESEARCH
2023Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP CANCER MEDICINE
2022Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study GroupTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2022Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)BREAST
2022Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial JAMA ONCOLOGY
2022PS2-3 Neoadjuvant pembrolizumab/placebo + chemo, followed by adjuvant pembrolizumab/placebo in early TNBC: Asian subgroupANNALS OF ONCOLOGY
2022PS2-1 Trastuzumab deruxtecan vs T-DM1 in HER2+ mBC in Asian subgroup: Results of the randomized phase 3 study DESTINY-Breast03ANNALS OF ONCOLOGY
2022Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer CANCERS
2022Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast CancerNEW ENGLAND JOURNAL OF MEDICINE
2022A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY
2022SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models CLINICAL & TRANSLATIONAL IMMUNOLOGY
2022Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinomaJOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
2022Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study JOURNAL OF BONE ONCOLOGY
2021Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade ResponsesHEPATOLOGY
2021Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors CANCERS
2021Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer FRONTIERS IN ONCOLOGY
2021Genomic landscape of extraordinary responses in metastatic breast cancer COMMUNICATIONS BIOLOGY
2020Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2020Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response BRITISH JOURNAL OF CANCER
2020Intermediate HER2 Expression Is Associated With Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Patients Aged 55 Years and OlderBREAST CANCER RESEARCH AND TREATMENT
2019MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven CancersCANCER RESEARCH
2019Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer EMBO MOLECULAR MEDICINE
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2019Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2018Can We Prevent Resistance to Osimertinib? Combination or SequentialJOURNAL OF THORACIC ONCOLOGY
2017Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcomaAPMIS
2015Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication PLOS ONE
2014Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutationsLUNG CANCER
2014Ifosfamide-induced Fanconi syndrome with diabetes insipidus KOREAN JOURNAL OF INTERNAL MEDICINE
2014Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaLUNG CANCER
2013Changing treatment patterns in elderly patients with resectable colon cancerASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2013FOXP3 Expression Is Related to High Ki-67 Index and Poor Prognosis in Lymph Node-Positive Breast Cancer PatientsONCOLOGY
2012신장 재이식 환자의 다발성 내장 침범 카포시육종에서 Sirolimus 치료를 통한 부분 관해 및 이식신 보존 1예 Journal of the Korean Society for Transplantation
1

Browse

Links